Patents by Inventor Sei-Yu Chen

Sei-Yu Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080267863
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating colon cancer.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 30, 2008
    Inventors: Roberto A. Macina, Sei-Yu Chen, Jason Pluta, Yongming Sun, Herve E. Recipon
  • Patent number: 7326402
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating cancer.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: February 5, 2008
    Assignee: diaDexus, Inc.
    Inventors: Herve Recipon, Roberto A. Macina, Sei-Yu Chen, Yongming Sun
  • Publication number: 20050153332
    Abstract: The invention relates to CSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: November 30, 2004
    Publication date: July 14, 2005
    Inventors: Roberto Macina, Sei-Yu Chen, Jason Pluta, Yongming Sun, Herve Recipon
  • Publication number: 20050152837
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating cancer.
    Type: Application
    Filed: February 28, 2005
    Publication date: July 14, 2005
    Inventors: Herve Recipon, Roberto Macina, Sei-Yu Chen, Yongming Sun
  • Patent number: 6902890
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating cancer.
    Type: Grant
    Filed: November 3, 2000
    Date of Patent: June 7, 2005
    Assignee: diaDexus, Inc.
    Inventors: Herve Recipon, Roberto A. Macina, Sei-Yu Chen, Yongming Sun
  • Publication number: 20050037419
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.
    Type: Application
    Filed: October 5, 2004
    Publication date: February 17, 2005
    Inventors: Herve Recipon, Yongming Sun, Sei-Yu Chen, Chenghua Liu, Leah Turner
  • Publication number: 20050026211
    Abstract: The invention relates to LSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: September 2, 2004
    Publication date: February 3, 2005
    Inventors: Sei-Yu Chen, Roberto Macina, Yongming Sun, Herve Recipon
  • Patent number: 6846650
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: January 25, 2005
    Assignee: diaDexus, Inc.
    Inventors: Herve E. Recipon, Yongming Sun, Sei-Yu Chen, Chenghua Liu, Leah R. Turner
  • Publication number: 20050014710
    Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research.
    Type: Application
    Filed: August 29, 2002
    Publication date: January 20, 2005
    Inventors: Yongming Sun, Chenghua Liu, Sei-Yu Chen
  • Publication number: 20030211039
    Abstract: The invention relates to CSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: March 20, 2003
    Publication date: November 13, 2003
    Inventors: Roberto A. Macina, Sei-Yu Chen, Jason Pluta, Yongming Sun, Herve Recipon
  • Publication number: 20030180817
    Abstract: The invention relates to CSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: May 29, 2001
    Publication date: September 25, 2003
    Inventors: Roberto A. Macina, Sei-Yu Chen, Jason Pluta, Yongming Sun, Herve E. Recipon
  • Publication number: 20030175707
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate tissue, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.
    Type: Application
    Filed: November 6, 2001
    Publication date: September 18, 2003
    Inventors: Yongming Sun, Herve E. Recipon, Sei-Yu Chen, Chenghua Liu
  • Publication number: 20030068624
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.
    Type: Application
    Filed: October 26, 2001
    Publication date: April 10, 2003
    Inventors: Herve E. Recipon, Yongming Sun, Sei-Yu Chen, Chenghua Liu, Leah R. Turner
  • Publication number: 20030064377
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate tissue, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.
    Type: Application
    Filed: November 6, 2001
    Publication date: April 3, 2003
    Inventors: Yongming Sun, Herve E. Recipon, Sei-Yu Chen, Chenghua Liu
  • Publication number: 20030064378
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.
    Type: Application
    Filed: October 26, 2001
    Publication date: April 3, 2003
    Inventors: Herve E. Recipon, Yongming Sun, Sei-Yu Chen, Chenghua Liu, Leah R. Turner
  • Publication number: 20030049617
    Abstract: The invention relates to LSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: February 20, 2001
    Publication date: March 13, 2003
    Inventors: Sei-Yu Chen, Roberto A. Macina, Yongming Sun
  • Publication number: 20030039983
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate tissue, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.
    Type: Application
    Filed: November 1, 2001
    Publication date: February 27, 2003
    Inventors: Yongming Sun, Herve E. Recipon, Sei-Yu Chen, Chenghua Liu
  • Publication number: 20030039986
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate tissue, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.
    Type: Application
    Filed: November 5, 2001
    Publication date: February 27, 2003
    Inventors: Yongming Sun, Herve E. Recipon, Sei-Yu Chen, Chenghua Liu
  • Publication number: 20030017468
    Abstract: The invention relates to LSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: August 27, 2001
    Publication date: January 23, 2003
    Inventors: Sei-Yu Chen, Roberto A. Macina, Yongming Sun, Herve E. Recipon
  • Publication number: 20020183500
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.
    Type: Application
    Filed: November 20, 2001
    Publication date: December 5, 2002
    Inventors: Roberto Macina, Herve A. Recipon, Sei-Yu Chen, Yongming Sun, Chenghua Liu